Patent · US Active

Pharmaceutical composition comprising a GLP-1 agonist and methionine

US9707176B2 · kind B2 · utility

4Cited by

138References

30Claims

0Family size

Assignee

Sanofi-Aventis Deutschland GMBH · DE

Inventors

Anette Brunner-Schwarz · Frankfurt, DE
Werner Mueller · Cologne, DE
Verena Siefke-Henzler · Frankfurt, DE

Key dates

Filing date	Nov 11, 2010
Grant date	Jul 18, 2017
Priority date	—
Expiry date	Nov 11, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P3/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivates where appropriate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.